Key result
The REMOTE study is a randomized trial designed to evaluate whether telemonitoring or telemedicine reduces the time to achieve blood pressure control among 444 patients with uncontrolled hypertension.
Why the study?
Does telemonitoring or telemedicine improve the time to control of home blood pressure in patients with uncontrolled hypertension compared to usual care?
RCT (n=444)
randomly assigned
Does telemonitoring or telemedicine improve the time to control of home blood pressure in patients with uncontrolled hypertension compared to usual care?
This study design paper outlines a trial to determine if telemonitoring or telemedicine can reduce the time to achieve blood pressure control in patients with uncontrolled hypertension.
Telemonitoring with video visits improves HBP control over usual care; extends RCT evidence for telemedicine hypertension management.
PURPOSE: Although self-measurement of home blood pressure (HBP) is common in Japan and HBP telemonitoring via the Internet is possible, whether telemonitoring improves HBP control better than conventional practice remains unclear. Furthermore, hypertension care with online communication using telemonitored HBP is feasible, whereas the efficacy and safety of such telemedicine have not been established. We aim to compare traditional care, care with office visits using HBP telemonitoring, and antihypertensive telemedicine based on HBP telemonitoring. METHODS AND DESIGN: In total, 444 patients with uncontrolled hypertension will be recruited and randomly assigned to three groups: (1) control: usual care with office visits and HBP self-report, (2) telemonitoring: weekly assessment of transmitted HBP by physicians and treatment adjustment upon office visits, or (3) telemedicine: online communication instead of office visits to adjust medication using telemonitored HBP. Primary outcome is the time to control of HBP, and secondary outcomes include achieved HBP levels, adherence, treatment intensity, adverse events, patient satisfaction and cost-effectiveness. DISCUSSION: Hypertension care with telemonitoring and telemedicine are expected to require shorter time to achieve HBP control compared to usual care. Combining HBP telemonitoring with telemedicine may lower the hurdles for starting and persisting to hypertension treatment and eventually reduce cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Yatabe et al. (2017) conducted an RCT in Uncontrolled hypertension (n=444). Telemonitoring or telemedicine based on home blood pressure vs. Usual care with office visits and home blood pressure self-report was evaluated on Time to control of home blood pressure. The REMOTE study is a randomized trial designed to evaluate whether telemonitoring or telemedicine reduces the time to achieve blood pressure control among 444 patients with uncontrolled hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: